ALLR - CIK 0001860657
Allarity Therapeutics, Inc. has filed 388 documents with the SEC between 2021 and 2026. The most frequent type is major company event (145 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| 424B3 | - | 2022-06-30 | - |
| Major company event | 8-K | 2022-06-30 | 2022-06-27 |
| Major company event | 8-K | 2022-06-10 | 2022-06-06 |
| 424B3 | - | 2022-06-07 | - |
| EFFECT | - | 2022-06-06 | - |
| POS AM | - | 2022-06-03 | - |
| Major company event | 8-K | 2022-05-27 | 2022-05-27 |
| Quarterly report | 10-Q | 2022-05-27 | 2022-03-31 |
| Major company event | 8-K | 2022-05-27 | 2022-05-27 |
| Major company event (amended) | 8-K/A | 2022-05-19 | 2022-05-16 |
| NT 10-Q | - | 2022-05-17 | 2022-03-31 |
| Major company event | 8-K | 2022-05-17 | 2022-05-16 |
| Annual report | 10-K | 2022-05-17 | 2021-12-31 |
| Quarterly report (amended) | 10-Q/A | 2022-05-17 | 2021-09-30 |
| Major company event | 8-K | 2022-05-06 | 2022-05-04 |
| Major company event | 8-K | 2022-04-22 | 2022-04-20 |
| Major company event | 8-K | 2022-04-18 | 2022-04-12 |
| 424B3 | - | 2022-04-01 | - |
| Major company event | 8-K | 2022-04-01 | 2022-03-28 |
| Major company event (amended) | 8-K/A | 2022-04-01 | 2022-03-25 |
| NT 10-K | - | 2022-04-01 | 2021-12-31 |
| Major company event | 8-K | 2022-03-31 | 2022-03-25 |
| Passive ownership stake (update) | SC 13G/A | 2022-01-20 | - |
| Major company event | 8-K | 2022-01-18 | 2022-01-14 |
| Major company event | 8-K | 2022-01-06 | 2022-01-02 |
| Passive ownership stake | SC 13G | 2021-12-27 | - |
| Major company event | 8-K | 2021-12-22 | 2021-12-21 |
| Major company event | 8-K | 2021-12-22 | 2021-12-17 |
| Passive ownership stake | SC 13G | 2021-12-22 | - |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| New insider ownership | 3 | 2021-12-22 | 2021-12-20 |
| 424B3 | - | 2021-12-21 | - |
| EFFECT | - | 2021-12-20 | - |
| Major company event | 8-K | 2021-12-20 | 2021-12-14 |
| Exchange certification | CERT | 2021-12-16 | - |
| Company correspondence | CORRESP | 2021-12-16 | - |
| Company correspondence | CORRESP | 2021-12-16 | - |
| S-1/A | - | 2021-12-16 | - |
| SEC correspondence | UPLOAD | 2021-12-16 | - |
| S-1/A | - | 2021-12-15 | - |
| 8-A12B | - | 2021-12-13 | - |
| Major company event | 8-K | 2021-12-10 | 2021-12-07 |